Cite

HARVARD Citation

    Fu, X. et al. (2022). The Efficacy and Safety of Adjuvant Lomustine to Chemotherapy for Recurrent Glioblastoma: A Meta-analysis of Randomized Controlled Studies. Clinical neuropharmacology. 45 (6), pp. 162-167. [Online]. 
  
Back to record